MDIC seeks participation in new digital pathology and AI collaborative effort

MDIC, FDA and Digital Pathology Association (DPA) are working to prioritize the areas of Digital Pathology and AI where MDIC can bring industry, users, government, insurance companies, and patients together to collaboratively work on several new projects. This alliance aims to work on:

  • Temporary framework to synergize and tackle larger scale projects

  • Harmonizing & standardizing a reference set to be used in end to end workflow by:

    • Creating tools and datasets

    • Progressing and enabling market access

    • Creating clarity on regulatory pathways via mock submissions

    • Harmonizing efforts between various stakeholders to optimize interoperability, integration and implementation

https://mdic.org/mdic-seeks-participation-in-new-digital-pathology-collaborative-effort/

Previous
Previous

Alliance Survey

Next
Next

Alliance Meeting at the FDA